KYMR · Kymera Therapeutics, Inc. · Share Buybacks
$127.57
+0.40 (+0.31%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$10.89B
Shares
85.37M
Volume · Nov 13
808.83K
Avg daily vol (3M)
828.66K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1815442
CUSIP
501575104
13F (30d)
236 filings
211 filers
Visit website
Investor relations